CoChat
Sign Up
Cited by 610Antifungal resistance and susceptibilityFungal Infections and StudiesYeasts and Rust Fungi Studies

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Epidemiology and risk factors for invasive candidiasis

Open access
Yapar, Nur·2014·Therapeutics and Clinical Risk Management
DOI 10.2147/tcrm.s40160PMC PMC3928396
Open this paper in CoChat — free accountOpen PDF

Abstract

The number of immunosuppressive patients has increased significantly in recent years. These patients are at risk for opportunistic infections, especially fungal infections. Candidiasis is one of the most frequent fungal infections determined in these immunosuppressive patients and its epidemiology has changed over the last two decades. Recently, new antifungal agents and new therapy strategies such as antifungal prophylaxis, secondary prophylaxis, and preemptive therapy have come into use. These changes resulted in the alteration of Candida species causing invasive infections. The incidence of Candida albicans was decreased in many countries, especially among patients with immunosuppressive disorders, while the incidence of species other than C. albicans was increased. In this review, incidence, risk factors, and species distribution of invasive candidiasis are discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/tcrm.s40160

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Flagged first, then by citations

Show all 70 references

Research works printed but not linked: 2

  1. [7]Lewis RE Overview of the changing epidemiology of candidemia Curr Med Res Opin 2009 25 7 1732 1740 19519284
  2. [48]Yapar N Akan M Avkan-Oguz V Ergon M Hancer M Doluca-Yucesoy M Risk factors and the incidence of candidemia in the intensive care unit: A 5-year cross-sectional study Proceedings of Twentieth European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) April 10–14, 2010 Vienna, Austria Wiley-Blackwell 2010

Cited by

Sorted by citations

Items 501–600 of 610

Related

See all

Metadata

Authors
Yapar, N.
Affiliations
Dokuz Eylül University (TR)
Corresponding author
Yapar, Nur
ORCID
Yapar, Nur
Venue
Therapeutics and Clinical Risk Management
Publisher
Informa UK Limited
Published
2014-02
Volume
10
Pages
95
ISSN
  • 1176-6336 (ISSN-L)
  • 1178-203X
DOI
10.2147/tcrm.s40160
PMC
PMC3928396
OpenAlex
W2149946566
Cited by
610
References
70
Citations by year
2026: 13 · 2025: 29 · 2024: 42 · 2023: 39 · 2022: 48 · 2021: 69 · 2020: 93 · 2019: 74 · 2018: 60 · 2017: 54 · 2016: 44 · 2015: 32 · 2014: 11
FWCI
6.53
Type
journal article
Language
en
Open access
Licence
Locations
  • Therapeutics and Clinical Risk Management (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
  • Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
Keywords
invasive candidiasis, Candida albicans, non-albicans Candida, immunosuppression, opportunistic fungal infection, risk factors, epidemiology, antifungal prophylaxis, secondary prophylaxis, preemptive antifungal therapy, species distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review